EUROCARE – what does the international benchmark data tell us?
What can you expect in this session? The EUROCARE project will be presented by Roberta de Angelis as an excellent example of an international effort to collect and compare international cancer survival data. Tit Albreht, as an expert in the field of international health care systems, will focus on differences in European Cancer Care and elucidate the impact of the system level on cancer outcomes. In the concluding discussion the following question will be addressed: How comparable are these data? What are the pitfalls in interpreting the results? Which effect tend to have local factors on this outcome data? Is this kind of benchmarking beneficial or resulting in any harms which should be considered?
The session is in English.
Dr. Roberta de Angelis (Rome, IT)
Dr. Roberta de Angelis works and researches at the Istituto Superiore di Sanità (ISS, National Center for Epidemiology, Surveillance and Health Promotion) in Rome, Italy, and is member of the EUROCARE Scientific Direction. EUROCARE is the largest collaborative research project on cancer survival in Europe, involving a growing number of population-based cancer registries across Europe. The objectives of the study are: to provide an updated description of trends and differences in cancer survival in European countries, to measure cancer prevalence and to investigate treatment patterns of cancer patients.
Tit Albreht is a Senior Health Services and Health Systems Researcher at the National Institute of Public Health of Slovenia. He is specialised in Social Medicine and having completed his PhD studies with the University of Amsterdam, he dedicates his research to the exploration of the health services nationally and internationally, interested in performance of health systems, evidence based health policy, health workforce planning and mobility and development of more efficient health care, especially in the field of non-communicable diseases. He is an associate professor of public health with the Medical Faculty in Ljubljana and a member of the Scientific Committee of the European Public Health Association. He acts as a reviewer in several international and national medical and public health scientific journals. Since 2006 he has been actively involved in the development of cancer policies at the European level – during the Slovenian presidency to the Council of the EU and later as coordinator of Joint Actions on cancer policies at the EU level – European Partnership for Action Against Cancer (EPAAC), Cancer Control (CanCon) and the most recent one, innovative Partnership for Action Against Cancer (iPAAC). He worked in a number of projects for policy support in different countries in Southeastern Europe, e.g. Bosnia and Herzegovina, Macedonia, Moldova, Montenegro, Serbia and also in Kazakhstan. These consultancies included: support in development of legal acts in the area of public health, cancer control and public health intervention. All of these were in support of the policies of the respective ministries of health. | photo: www.denisabbonato.com
Dr.rer.medic.Christoph Kowalski has been working in the certification unit at the Deutsche Krebsgesellschaft (German Cancer Society) since 2014.Among other things, he leads the studies for measuring the quality in certified prostate cancer centers (PCO study, funded by the Movember Foundation and the Help for Prostate Cancer Patients - FHbP) and colon cancer centers (EDIUM study, funded by the German Innovation Fund).|Photo: Luca Vecoli